FRX.TO
FENNEC PHARMACEUTICALS INC
TorontoCADEQUITY
Healthcare
DELAYED
Last price
15.49
▼ 0.14 (0.90%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
15.75
Prev close
15.63
Day high
15.75
Day low
15.49
Volume
616
Market cap
$543.19M
P/E (TTM)
—
52W range
7.59 – 17.64
Day trading desk
Gap from prior close
+0.77%
Prior close 15.63
VWAP
15.50
-0.04% from price
Relative volume
0.90×
Normal
Session range
1.68%
15.49 – 15.75
Position in range
0%
Near session low
ATR (14D)
0.62
4.01% of price
Prior day high
15.64
PDH
Prior day low
15.63
PDL
Bid / ask spread
—
Quote not published
Session volume
616
Avg 684
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-8.94%
-7.6%
1M
+8.93%
+5.2%
3M
+13.15%
+10.1%
6M
+28.87%
+17.8%
YTD
+46.13%
+33.8%
1Y
+38.30%
+18.3%
3Y
+45.72%
-28.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on FRX.TO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.02M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 3, 26 | RAYKOV ROSTISLAV CHRISTOV Former |
SELL | 10.00K | $95.80K | Direct |
| Jul 31, 26 | ANDRADE ROBERT C Chief Financial Officer |
STOCK | 1.70K | $0 | Direct |
| Jul 31, 26 | HACKMAN JEFFREY S Chief Executive Officer |
STOCK | 1.16K | $0 | Direct |
| Jul 31, 26 | CIOFFI CHRISTIANA MARIE Officer |
STOCK | 156 | $0 | Direct |
| Jul 31, 26 | EVANS TERRY L Officer |
STOCK | 168 | $0 | Direct |
| Jul 31, 26 | SAYAD PIERRE SARGIS PH.D. Officer |
STOCK | 168 | $0 | Direct |
| Jul 31, 26 | RAYKOV ROSTISLAV CHRISTOV Former |
STOCK | 2.78K | $0 | Direct |
| Jul 1, 26 | RAYKOV ROSTISLAV CHRISTOV Former |
SELL | 9.60K | $99.93K | Direct |
| Jul 1, 26 | RAYKOV ROSTISLAV CHRISTOV Former |
STOCK | 2.78K | $0 | Direct |
| Jul 1, 26 | RAYKOV ROSTISLAV CHRISTOV Former |
CONVERSION | 15.60K | $38.21K | Direct |
| Jun 30, 26 | ANDRADE ROBERT C Chief Financial Officer |
STOCK | 1.70K | $0 | Direct |
| Jun 30, 26 | HACKMAN JEFFREY S Chief Executive Officer |
STOCK | 1.16K | $0 | Direct |
| Jun 30, 26 | CIOFFI CHRISTIANA MARIE Officer |
STOCK | 156 | $0 | Direct |
| Jun 30, 26 | EVANS TERRY L Officer |
STOCK | 168 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDRADE ROBERT C |
Chief Financial Officer | 292.68K | Stock Award(Grant) |
CIOFFI CHRISTIANA MARIE |
Officer | 24.49K | Stock Award(Grant) |
EVANS TERRY L |
Officer | 21.35K | Stock Award(Grant) |
HACKMAN JEFFREY S |
Chief Executive Officer | 65.14K | Stock Award(Grant) |
RALLIS CHRISTOPHER ANIGERON |
Director | 63.08K | Sale |
RAYKOV ROSTISLAV CHRISTOV |
Former | 131.63K | Sale |
SAYAD PIERRE SARGIS PH.D. |
Officer | 21.35K | Stock Award(Grant) |
SOUTHPOINT CAPITAL ADVISORS, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
Fundamentals
Market cap$543.19M
Enterprise value$501.94M
Revenue (TTM)$59.22M
Gross profit$55.51M
EBITDA$-1.02M
Net income$-3.25M
EPS (TTM)$-0.17
Free cash flow$1.07M
Total cash$41.25M
Total debt$0
Book value / share$1.68
Shares outstanding35.07M
Float19.78M
Short % of float0.08%
Dividend yield—
Beta (5Y)1.07
Valuation & profitability ratios
Trailing P/E—
Forward P/E11.70
PEG ratio—
Price / sales—
Price / book9.22
EV / revenue8.48
EV / EBITDA-491.46
Gross margin93.73%
Operating margin9.72%
Profit margin-5.49%
Return on equity-18.58%
Return on assets-1.17%
Debt / equity—
Current ratio5.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $44.64M | $47.54M | $21.25M | $1.53M | -6.1% |
| Operating revenue | $44.64M | $47.54M | $21.25M | $1.53M | -6.1% |
| Cost of revenue | $3.76M | $3.18M | $1.26M | $86.00K | +18.2% |
| Gross profit | $40.88M | $44.35M | $19.99M | $1.45M | -7.8% |
| Research & development | $250.00K | $307.00K | $56.00K | $3.53M | -18.6% |
| Selling, general & admin | $46.91M | $41.48M | $32.71M | $20.51M | +13.1% |
| Total operating expense | $47.22M | $41.88M | $33.05M | $24.19M | +12.8% |
| Operating income | -$6.35M | $2.48M | -$13.06M | -$22.74M | -356.0% |
| Net interest income | -$1.29M | -$2.39M | -$2.95M | -$783.00K | +45.8% |
| Pre-tax income | -$9.63M | -$71.00K | -$16.05M | -$23.71M | -13,470.4% |
| Tax provision | $106.00K | $365.00K | $0 | — | -71.0% |
| Net income | -$9.74M | -$436.00K | -$16.05M | -$23.71M | -2,134.2% |
| Net income to common | -$9.74M | -$436.00K | -$16.05M | -$23.71M | -2,134.2% |
| Basic EPS | -0.35 | 0.00 | -0.60 | -0.90 | — |
| Diluted EPS | -0.35 | 0.00 | -0.60 | -0.90 | — |
| EBIT | -$7.55M | $4.00M | -$12.65M | -$22.74M | -289.0% |
| EBITDA | -$7.45M | $4.80M | -$12.36M | -$22.59M | -255.3% |
| Basic shares | 28.58M | 27.29M | 26.57M | 26.27M | +4.7% |
| Diluted shares | 28.58M | 27.29M | 26.57M | 26.27M | +4.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $36.79M | $26.63M | $13.27M | $23.77M | — | +38.1% |
| Cash & short-term investments | $36.79M | $26.63M | $13.27M | $23.77M | — | +38.1% |
| Accounts receivable | $23.22M | $12.88M | $8.81M | $1.54M | — | +80.2% |
| Inventory | $1.56M | $1.06M | $2.16M | $576.00K | — | +47.6% |
| Total current assets | $67.04M | $44.12M | $26.86M | $26.73M | — | +51.9% |
| Total assets | $70.55M | $44.95M | $26.86M | $26.94M | — | +57.0% |
| Total current liabilities | $10.52M | $6.92M | $7.55M | $4.61M | — | +52.0% |
| Long-term debt | — | $19.34M | $30.93M | $24.90M | $4.99M | — |
| Total debt | $0 | $19.34M | $30.95M | $24.90M | — | -100.0% |
| Retained earnings | -$229.42M | -$219.68M | -$219.25M | -$203.20M | — | -4.4% |
| Shareholder equity | $35.47M | -$5.87M | -$11.62M | -$2.57M | — | +704.1% |
| Working capital | $56.52M | $37.20M | $19.30M | $22.12M | — | +51.9% |
| Net tangible assets | $35.47M | -$5.87M | -$11.62M | -$2.57M | — | +704.1% |
| Shares issued | 34.16M | 27.53M | 27.03M | 26.36M | — | +24.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$9.74M | -$436.00K | -$16.05M | -$23.71M | -2,134.2% |
| Depreciation & amortisation | $103.00K | $800.00K | $0 | — | -87.1% |
| Stock-based compensation | $7.03M | $5.06M | $5.35M | $4.09M | +39.0% |
| Change in working capital | -$12.04M | $16.94M | -$6.78M | $1.10M | -171.1% |
| Operating cash flow | -$12.47M | $26.98M | -$17.14M | -$18.06M | -146.2% |
| Financing cash flow | $22.63M | -$13.62M | $6.64M | $20.73M | +266.2% |
| Free cash flow | -$12.47M | $26.98M | -$17.14M | -$18.06M | -146.2% |
| End cash position | $36.79M | $26.63M | $13.27M | $23.77M | +38.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $15.11M | $13.78M | $12.46M | $9.65M | $8.75M | +9.7% |
| Operating revenue | $15.87M | $9.22M | $13.67M | $10.94M | $10.81M | +72.1% |
| Cost of revenue | $570.00K | $1.76M | $660.00K | $967.00K | $373.00K | -67.7% |
| Gross profit | $14.54M | $12.01M | $11.80M | $8.69M | $8.38M | +21.0% |
| Research & development | $49.00K | $20.00K | $29.00K | $107.00K | $94.00K | +145.0% |
| Selling, general & admin | $14.61M | $14.55M | $11.96M | $11.31M | $9.09M | +0.4% |
| Total operating expense | $14.66M | $14.59M | $12.00M | $11.42M | $9.20M | +0.4% |
| Operating income | -$119.00K | -$2.58M | -$201.00K | -$2.73M | -$821.00K | +95.4% |
| Net interest income | $332.00K | -$80.00K | -$434.00K | -$436.00K | -$356.00K | +515.0% |
| Pre-tax income | $201.00K | -$4.68M | -$638.00K | -$3.15M | -$1.17M | +104.3% |
| Net income | $201.00K | -$4.79M | -$638.00K | -$3.15M | -$1.17M | +104.2% |
| Net income to common | $201.00K | -$4.79M | -$638.00K | -$3.15M | -$1.17M | +104.2% |
| Basic EPS | 0.01 | -0.17 | -0.02 | -0.11 | -0.04 | +105.9% |
| Diluted EPS | 0.01 | -0.17 | -0.02 | -0.11 | -0.04 | +105.9% |
| EBIT | $208.00K | -$4.37M | -$52.00K | -$2.56M | -$573.00K | +104.8% |
| EBITDA | $234.00K | -$4.35M | -$26.00K | -$2.53M | -$547.00K | +105.4% |
| Basic shares | 34.34M | 31.18M | 27.89M | 27.66M | 27.58M | +10.1% |
| Diluted shares | 35.55M | 31.18M | 27.89M | 27.66M | 27.58M | +14.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $40.18M | $36.79M | $21.95M | $18.70M | $22.68M | — | +9.2% |
| Cash & short-term investments | $40.18M | $36.79M | $21.95M | $18.70M | $22.68M | — | +9.2% |
| Accounts receivable | $18.76M | $23.22M | $19.34M | $17.50M | $15.45M | — | -19.2% |
| Inventory | $1.86M | $1.56M | $2.48M | $2.20M | $1.40M | — | +18.6% |
| Total current assets | $66.88M | $67.04M | $46.06M | $40.79M | $42.98M | — | -0.2% |
| Total assets | $71.82M | $70.55M | $49.26M | $44.88M | $46.40M | — | +1.8% |
| Total current liabilities | $9.59M | $10.52M | $9.81M | $8.41M | $8.37M | — | -8.9% |
| Long-term debt | — | — | $19.38M | $19.36M | $19.35M | $19.34M | — |
| Total debt | — | $0 | $19.38M | $19.36M | $19.35M | $19.34M | — |
| Total liabilities | $34.15M | $35.08M | $53.75M | $52.34M | $52.28M | — | -2.7% |
| Retained earnings | -$229.22M | -$229.42M | -$224.64M | -$224.00M | -$220.85M | — | +0.1% |
| Shareholder equity | $37.67M | $35.47M | -$4.49M | -$7.46M | -$5.88M | — | +6.2% |
| Working capital | $57.29M | $56.52M | $36.25M | $32.38M | $34.60M | — | +1.4% |
| Net tangible assets | $37.67M | $35.47M | -$4.49M | -$7.46M | -$5.88M | — | +6.2% |
| Shares issued | 34.54M | 34.16M | 28.06M | 27.62M | 27.59M | — | +1.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $201.00K | -$4.79M | -$637.00K | -$3.15M | -$1.17M | +104.2% |
| Depreciation & amortisation | $26.00K | $26.00K | $26.00K | $25.00K | $26.00K | 0.0% |
| Stock-based compensation | $990.00K | $2.52M | $2.22M | $1.49M | $798.00K | -60.7% |
| Change in working capital | $2.67M | -$6.31M | $1.54M | -$3.21M | -$4.07M | +142.4% |
| Operating cash flow | $2.38M | -$5.96M | $1.49M | -$3.69M | -$4.32M | +139.9% |
| Financing cash flow | $1.01M | $20.80M | $1.75M | -$284.00K | $359.00K | -95.1% |
| Free cash flow | $2.38M | -$5.96M | $1.49M | -$3.69M | -$4.32M | +139.9% |
| End cash position | $40.18M | $36.79M | $21.95M | $18.70M | $22.68M | +9.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.03 | 0.07 | +153.4% |
| Dec 2025 | 0.05 | -0.14 | -351.7% |
| Sep 2025 | -0.03 | -0.03 | +9.0% |
| Jun 2025 | -0.04 | -0.15 | -263.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.03 | 4 | $16.12M | +67.0% |
| Next quarter | 0.20 | 5 | $20.85M | +51.3% |
| Current year | 0.47 | 5 | $72.90M | +63.3% |
| Next year | 1.32 | 5 | $103.15M | +41.5% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusSTRONG BUY
Strong buy / Buy2 / 4
Hold0
Sell / Strong sell0 / 0
Held by insiders14.31%
Held by institutions54.32%
Institutions holding145
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
16.50
-6.10% from price
SMA 20
15.46
+0.20% from price
SMA 50
14.72
+5.23% from price
SMA 100
12.67
+22.24% from price
SMA 200
11.70
+32.43% from price
EMA 12
16.02
-3.30% from price
EMA 26
15.49
+0.00% from price
EMA 50
14.69
+5.41% from price
RSI (14)
50.3
Neutral
MACD (12,26,9)
0.53
Hist -0.05
ATR (14)
0.62
4.01% of price
Realised vol 30D
62.8%
Annualised
Bollinger upper
17.98
20, 2σ
Bollinger lower
12.94
20, 2σ
50 / 200 cross
Golden
14.72 vs 11.70
Trend bias
Above 200
+32.43%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.92
Less volatile than market
Correlation to SPY
0.18
Largely independent
Realised vol 30D
62.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-41.1%
Peak to trough
Max drawdown 5Y
-62.8%
Peak to trough
ATR 14
0.62
4.01% of price
Beta (reported)
1.07
5Y monthly, from filing
Short interest
Shares short
24.70K
Prior 24.76K
Change vs prior
-0.2%
Shorts covering
% of float
0.08%
Normal
% of shares out
0.07%
Against total outstanding
Days to cover
48.9
Crowded exit
Float
19.78M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Aug 12, 26 | Wedbush | MAINTAINED | Outperform | Outperform |
| May 22, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 16, 26 | Wedbush | MAINTAINED | Outperform | Outperform |
| Jan 9, 26 | Piper Sandler | INITIATED | — | Overweight |
| Aug 21, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 15, 25 | Craig-Hallum | MAINTAINED | Buy | Buy |
| May 20, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 14, 25 | Craig-Hallum | MAINTAINED | Buy | Buy |
| Mar 11, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Dec 17, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 22, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:3
Split dateSep 5, 2014
Headlines
Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
Motley Fool · 9m ago
Sell U.S. dollar versus these currencies, BCA says
Investing.com · 12m ago
Democrat Angie Nixon stunned politicos in Florida's primary. Can she win again?
Orlando Sentinel · 13m ago
Synaptics' CFO Disposed of Stock as an 88%-12% OnSemi Ownership Split Takes Shape. Here's What to Know
Motley Fool · 14m ago
The Ultimate Growth Stock to Buy With $1,000 Right Now -- It's Been My Best Stock Performer by Far
Motley Fool · 28m ago
The S&P 500 Just Did Something Seen Only 1 Other Time Since 1871 — and It's Not Good News for Wall Street
Motley Fool · 29m ago
AWS Was Lagging Microsoft Azure and Google Cloud in Growth—Is Amazon Finally Catching Up?
Insider Monkey · 32m ago
Iran warns neighbours against joining U.S. sanctions as Hormuz stays closed
Investing.com · 34m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.